Document:

SECURITIES PURCHASE
AGREEMENT

 

THIS SECURITIES
PURCHASE AGREEMENT (this “Agreement”) is made as of the later date set forth on the signature pages hereto,
by and among BioDrain Medical, Inc., a Minnesota corporation (the “Company”), and the purchaser whose name and
address are set forth on the signature page annexed hereto (the “Purchaser”). The foregoing parties are sometimes
referred to hereinafter individually as a “Party” or collectively as the “Parties.”

 

RECITALS

 

WHEREAS, pursuant
to the Subscription Application of the Purchaser of even date herewith (each a “Subscription Application”),
and pursuant to Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506
promulgated thereunder, the Company desires to sell to the Purchaser and the Purchaser desires to acquire from the Company that
number of units of the Company’s securities (the “Units”) as are set forth on the Purchaser’s signature
page annexed hereto, at a price of $0.07 per Unit, subject to the terms and conditions of this Agreement and the other documents
or instruments contemplated hereby; and

 

WHEREAS, each
Unit consists of: (i) one share of the Company’s $0.01 par value common stock (the “Common Stock”), and
(ii) a five-year warrant, in the form of Exhibit A attached hereto, to purchase one (1) share of Common Stock at an exercise
price of $0.15 per share (collectively, “Warrants”).

 

NOW, THEREFORE,
in consideration of the mutual covenants and agreements hereinafter set forth, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Parties do hereby covenant and agree as follows:

 

AGREEMENT

 

Section 1.Sale and Issuance of Units.

 

1.1Subject to the
terms and conditions of this Agreement, the Company’s board of directors has authorized the sale and issuance of up to 7,142,858
Units (the “Offering”). At the Closing (as defined below), the Company shall sell and issue to the Purchaser,
and the Purchaser shall purchase from the Company, the number of Units set forth on the Purchaser’s signature page hereto.
The Company intends to enter into this same form of purchase agreement with certain other purchasers (collectively, the “Other
Purchasers”, and collectively with the Purchaser, the “Purchasers”) and expects to complete sales
of Units to them. The maximum number of Units that the Company may sell to the Purchasers is 7,142,858, unless a higher amount
is authorized by the Company’s board of directors in its sole discretion. The Purchaser’s obligations hereunder are
expressly not subject to or conditioned on the purchase of Units by any or all of such Other Purchasers.

 

1.2The aggregate
purchase price for the Units to be purchased by the Purchaser (the “Purchase Price”) shall be the amount set
forth on the Purchaser’s signature page hereto.

 

    	  

    	 

    
 

Section 2.The Closing.

 

2.1The closing
of the sale and issuance to the Purchaser (the “Closing”) shall take place on the date that when the Company
receives from Purchaser (i) this Agreement and the Purchaser's Subscription Application duly executed by Purchaser; and (ii) payment
of the Purchase Price, which shall be made contemporaneously with the execution and delivery of the this Agreement and the Subscription
Application, in immediately available funds via wire transfer or a certified check equal to the Purchase Price set forth on the
Purchaser’s signature page hereto.

 

2.2Within ten (10)
business days of the Closing, the Company shall instruct its transfer agent to issue and deliver to the Purchaser a certificate
representing the Common Stock and Warrants underlying the Units purchased by the Purchaser.

 

Section 3.Representations and Warranties
of the Company.

 

The Company hereby
represents and warrants to the Purchaser as follows:

 

3.1Organization.

 

The Company is duly
organized, validly existing and in good standing under the laws of the State of Minnesota and is qualified to conduct its business
as a foreign corporation in each jurisdiction where the failure to be so qualified would have a material adverse effect on the
Company.

 

3.2Authorization of Agreement, Etc.

 

The execution, delivery,
and performance by the Company of its obligations under this Agreement, the Subscription Application, the Warrants and each other
document or instrument contemplated hereby or thereby (collectively, the “Transaction Documents”) has been duly
authorized by all requisite corporate action on the part of the Company; and this Agreement and the Transaction Documents have
been duly executed and delivered by the Company. Each of the Transaction Documents, when executed and delivered by the Company,
constitutes the valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject
to applicable bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium, or other similar laws affecting creditors’
rights and remedies generally, and subject, as to enforceability, to general principles of equity (regardless of whether enforcement
is sought in a proceeding at law or in equity).

 

3.3Issuance of Common Stock and
Warrants.

 

The Units are
duly authorized and, when paid for and issued in accordance with the Transaction Documents, will be duly and validly issued, fully
paid, and nonassessable, free and clear of all liens.

 

Section 4.Representations and Warranties
of the Purchaser.

 

The Purchaser hereby
represents and warrants to the Company as follows:

 

    	2

    	 

    
 

4.1Authorization
of the Documents.

 

The Purchaser has all
requisite power and authority (corporate or otherwise) to execute, deliver, and perform its obligations under the Transaction Documents,
and the execution, delivery, and performance by the Purchaser of its obligations under the Transaction Documents has been duly
authorized by all requisite action on the part of the Purchaser and each such Transaction Document, when executed and delivered
by the Purchaser, shall constitute the valid and binding obligation of the Purchaser, enforceable against the Purchaser in accordance
with its terms, subject to applicable bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other similar
laws affecting creditors’ rights and remedies generally, and subject, as to enforceability, to general principles of equity
(regardless of whether enforcement is sought in a proceeding at law or in equity).

 

4.2Investment Representations.

 

All of the representations,
warranties, and information of the Purchaser as set forth in the Purchaser’s Subscription Application are incorporated by
reference herein, shall be deemed to be a part hereof, and shall be true and correct at the Closing with the same force and effect
as if made by the Purchaser as of the date thereof.

 

4.3Access to
Company Information.

 

The Purchaser acknowledges
that it has been afforded access and the opportunity to obtain all financial and other information concerning the Company that
such Purchaser desires (including the opportunity to meet with the Company’s executive officers, either in person or telephonically).
The Purchaser has reviewed copies of all reports filed by the Company (the “Filings”) with the Securities and
Exchange Commission (the “Commission”) under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), since December 31, 2009, all of which are available for review at www.sec.gov. The Purchaser further acknowledges
that it is familiar with the contents of the Filings and that there is no further information about the Company that the Purchaser
desires in determining whether to acquire the Units in the Offering.

 

4.4Risk Factors

 

The Purchaser acknowledges
that the Company is a development stage company with limited revenues and currently not operating with positive cash-flow from
operations, and there can be no assurances that the Company will ever develop its operations as currently contemplated. The Purchaser
acknowledges that an investment in the Units is extremely speculative and that there is a substantial likelihood that the investor
will lose their entire investment.

 

4.5DTC Chill

 

Purchaser understands
and acknowledges that (i) the Company’s Common Stock is currently subject to a “DTC Chill” imposed by the Depository
Trust Company (the “DTC”), thereby preventing any additional deposits of the Company’s shares of Common Stock
for depository and book-entry transfer services until such restriction has been lifted by DTC, (ii) while the Company is making
all efforts to ensure that the “DTC Chill” is lifted, including having provided evidence to the DTC in support of the
Company’s assertion that all of the deposits of the Company’s securities that are the subject of DTC’s request
for support were eligible for depository and book entry transfer services as of the dates of such deposits, there is no assurance
that the DTC will lift the restriction, and (iii) unless and until the restriction is lifted by the DTC, the shares of Common Stock
underlying the Units and issuable upon the exercise of the Warrants will not be eligible for depository and book entry transfer
services provided by DTC.

 

    	3

    	 

    
 

Section 5.Brokers and Finders.

 

The Company shall not
be obligated to pay any commission, brokerage fee, or finder’s fee based on any alleged agreement or understanding between
the Purchaser and a third person in respect of the transactions contemplated hereby. The Purchaser hereby agrees to indemnify the
Company against any claim by any third person for any commission, brokerage fee, finder’s fee, or other payment with respect
to this Agreement or the transactions contemplated hereby based on any alleged agreement or understanding between the Purchaser
and any such third person, whether express or implied from the actions of the Purchaser or anyone acting or purporting to act on
behalf of the Purchaser.

 

Section 6.Indemnification by the
Purchaser.

 

The Purchaser hereby
agrees to indemnify and defend (with counsel acceptable to the Company) the Company and its officers, directors, employees, and
agents and hold them harmless from and against any and all liability, loss, damage, cost, or expense, including costs and reasonable
attorneys’ fees, incurred on account of or arising from:

 

(a)any breach of or inaccuracy
in any of the Purchaser’s representations, warranties, or agreements made herein, in any of the Transaction Documents, or
in any document or instrument contemplated hereby or thereby; and

 

(b)any action,
suit, or proceeding based on a claim that the Purchaser’s representations, warranties or agreements made herein, in any of
the Transaction Documents, or in any document or instrument contemplated hereby or thereby, were inaccurate or misleading, or otherwise
cause for obtaining damages or redress from the Company or any current or former officer, director, employee, or agent of the Company
under the Securities Act.

 

Section 7.Successors
and Assigns.

 

This Agreement shall
bind and inure to the benefit of the Company, the Purchaser, and their respective successors and assigns.

 

Section 8.Entire
Agreement.

 

This Agreement and
the other writings and agreements referred to in this Agreement or delivered pursuant to this Agreement contain the entire understanding
of the Parties with respect to the subject matter hereof and supersede all prior agreements and understandings, whether written
or verbal, among the Parties with respect thereto.

 

    	4

    	 

    
 

Section 9.Notices.

 

All notices, demands
and requests of any kind to be delivered to any Party in connection with this Agreement shall be in writing and shall be deemed
to have been duly given if personally delivered or if sent by internationally-recognized overnight courier or by registered or
certified mail, return receipt requested and postage prepaid, addressed as follows:

 

if to the Company, to:

 

BioDrain Medical, Inc.

2915 Commers Drive, Suite 900

Eagan, MN 55121

Attention: Bob Myers, Acting Chief
Financial Officer

 

with a copy to:

 

Richardson & Patel LLP

750 Third Avenue

9th Floor

New York, NY 10017

Attention: Kevin Friedmann

 

if to the Purchaser, to:

 

at the address of the Purchaser
set forth on the Purchaser’s signature page hereto;

 

or to such other address
as the Party to whom notice is to be given may have furnished to the other Parties to this Agreement in writing in accordance with
the provisions of this Section. Any such notice or communication shall be deemed to have been received (i) in the case of personal
delivery, on the date of such delivery, (ii) in the case of internationally-recognized overnight courier, on the next business
day after the date when sent and (iii) in the case of mailing, on the third business day following that on which the piece of mail
containing such communication is posted.

 

Section 10.Amendments.

 

This Agreement may
not be modified or amended, nor may any provision of this Agreement be waived, except as evidenced by a written agreement duly
executed by Purchasers who hold a majority of the Common Stock and shares of Common Stock underlying Warrants acquired in the Offering.

 

Section 11.Governing Law; Waiver of
Jury Trial.

 

All questions concerning
the construction, interpretation, and validity of this Agreement shall be governed by and construed and enforced in accordance
with the domestic laws of the State of New York without giving effect to any choice or conflict of law provision or rule (whether
in the State of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than
the State of New York. In furtherance of the foregoing, the internal law of the State of New York will control the interpretation
and construction of this Agreement, even if under such jurisdiction’s choice of law or conflict of law analysis, the substantive
law of some other jurisdiction would ordinarily or necessarily apply.

 

    	5

    	 

    
 

Section 12.Submission to Jurisdiction.

 

Any legal action or
proceeding with respect to this Agreement may be brought in the courts of the State of New York and the United States of America
located in the Borough of Manhattan in the City of New York, New York, and, by execution and delivery of this Agreement, the Company
hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of the aforesaid courts.
The Purchaser hereby irrevocably waives, in connection with any such action or proceeding, any objection, including, without limitation,
any objection to the venue or based on the grounds of forum non conveniens, which it may now or hereafter have to the bringing
of any such action or proceeding in such respective jurisdictions. The Purchaser hereby irrevocably consents to the service of
process of any of the aforementioned courts in any such action or proceeding by the mailing of copies thereof by registered or
certified mail, postage prepaid, to it at its address as set forth herein.

 

Section 13.Severability.

 

It is the desire and
intent of the Parties that the provisions of this Agreement be enforced to the fullest extent permissible under the law and public
policies applied in each jurisdiction in which enforcement is sought. Accordingly, in the event that any provision of this Agreement
would be held in any jurisdiction to be invalid, prohibited, or unenforceable for any reason, such provision, as to such jurisdiction,
shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability
of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as
not to be invalid, prohibited, or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn,
without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in
any other jurisdiction.

 

Section 14.Independence of Agreements,
Covenants, Representations and Warranties.

 

All agreements and
covenants hereunder shall be given independent effect so that if a certain action or condition constitutes a default under a certain
agreement or covenant, the fact that such action or condition is permitted by another agreement or covenant shall not affect the
occurrence of such default, unless expressly permitted under an exception to such covenant. In addition, all representations and
warranties hereunder shall be given independent effect so that if a particular representation or warranty proves to be incorrect
or is breached, the fact that another representation or warranty concerning the same or similar subject matter is correct or is
not breached will not affect the incorrectness of or a breach of a representation and warranty hereunder. The exhibits and any
schedules annexed hereto are hereby made part of this Agreement in all respects.

 

    	6

    	 

    
 

Section 15.Counterparts.

 

This Agreement may
be executed in any number of counterparts, and each such counterpart of this Agreement shall be deemed to be an original instrument,
but all such counterparts together shall constitute but one agreement. Facsimile or PDF counterpart signatures to this Agreement
shall be acceptable and binding.

 

Section 16.Headings.

 

The section and paragraph
headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
of this Agreement.

 

Section 17.Expenses.

 

Each Party shall pay
its own fees and expenses incurred in connection with the negotiation, execution, delivery and performance of this Agreement, the
Transaction Documents and any document or instrument contemplated hereby or thereby.

 

Section 18.Preparation of Agreement.

 

The Company prepared
this Agreement and the Transaction Documents solely on its behalf. Each Party to this Agreement acknowledges that: (i) the Party
had the advice of, or sufficient opportunity to obtain the advice of, legal counsel separate and independent of legal counsel for
any other Party hereto; (ii) the terms of the transactions contemplated by this Agreement are fair and reasonable to such Party;
and (iii) such Party has voluntarily entered into the transactions contemplated by this Agreement without duress or coercion. Each
Party further acknowledges that such Party was not represented by the legal counsel of any other Party hereto in connection with
the transactions contemplated by this Agreement, nor was he or it under any belief or understanding that such legal counsel was
representing his or its interests. Each Party agrees that no conflict, omission, or ambiguity in this Agreement, or the interpretation
thereof, shall be presumed, implied, or otherwise construed against any other Party to this Agreement on the basis that such Party
was responsible for drafting this Agreement.

 

Section 19.Use of Proceeds.

 

The Company shall use
the net proceeds from the Offering for general working capital and general corporate purposes and debt service obligations.

 

Section 20.Signature Page.

 

It is hereby agreed
that the execution by the Purchaser of this Subscription Agreement, in the place set forth herein, will constitute agreement by
the Purchaser to be bound by the terms and conditions of (1) this Subscription Agreement and (2) the Warrant, in the form attached
hereto as Exhibit A.

 

 

 

[signature
pages follow]

 

    	7

    	 

    

 

IN WITNESS WHEREOF,
each of the undersigned has duly executed this Securities Purchase Agreement as of the later date set forth on the signature pages
below.

  

	 	 	 	COMPANY:
	 	 	 	 
	Date: _______________, 2013	 	BIODRAIN MEDICAL, INC.
	 	 	 	 
	 	 	 	 
	 	 	 	By:	 
	 	 	 	 	Name: Bob Myers
	 	 	 	 	Title: Chief Financial Officer

 

 

[Purchaser’s
Signature Page FollowS]

 

    	 

    	 

    

 

Purchaser
Signature Page to BioDrain Medical, Inc. 

Securities
Purchase Agreement

 

PURCHASER:

 

		 		 
	Print Name of Purchaser (Individual or	 	Print Name of Individual representing	 
	Institution)	 	Purchaser (if an Institution)	 
	 	 	 	 
	 	 	 	 
		 		 
	Title of Individual representing	 	Signature of Individual Purchaser or	 
	Purchaser (if an Institution)	 	Individual representing Purchaser	 
	 	 	 	 
	 	 	 	 
	Address:	 	 	 
	 	 	 	 
	 	 	 	 
	Telephone:	 	 	 
	 	 	 	 
	 	 	 	 
	Facsimile:	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	Number of Units	 	 	 
	 	 	 	 
	 	 	 	 
	Aggregate Purchase Price	 	 	 
	 	 	 	 
		 	 	 
	DateExhibit
10.1

 

TICC CLO
2012-1 LLC

NOTES

 

U.S.$44,000,000
Class A-1 Senior Secured Floating Rate Notes due 2023

U.S.$5,000,000
CLASS B-1 SENIOR SECURED FLOATING RATE NOTES DUE 2023

U.S.$5,750,000
Class C-1 Secured Deferrable Floating Rate Notes due 2023

U.S.$5,250,000
Class D-1 Secured Deferrable Floating Rate Notes due 2023

 

UPSIZE PURCHASE
AGREEMENT

 

as of January 24, 2013

 

Guggenheim Securities, LLC,

as the Initial Purchaser (the “Initial Purchaser”)

135 East 57th Street

7th Floor

New York, NY 10022

Attention: Paul M. Friedman

 

Ladies and Gentlemen:

 

Section 1.               
Authorization of Notes.

 

Pursuant to an Indenture,
dated August 23, 2012 (the “Indenture”), between TICC CLO 2012-1 LLC, a Delaware limited liability company,
as the issuer (the “Issuer”), and The Bank of New York Mellon Trust Company, National Association, as the trustee
(the “Trustee”), the Issuer issued and sold $88,000,000 Class A-1 Notes, $10,000,000 Class B-1 Notes, $11,500,000
Class C-1 Notes, $10,500,000 Class D-1 Notes (collectively, the “Initial Offered Notes”) and $40,000,000 Subordinated
Notes (the “Initial Subordinated Notes” and, together with the Initial Offered Notes, the “Initial
Notes”). Pursuant to a purchase agreement, dated as of August 13, 2012 (the “Initial Purchase Agreement”),
between the Issuer, TICC Capital Corp. (the “Company”) and Guggenheim Securities, LLC (“Guggenheim”),
Guggenheim initially purchased the Initial Offered Notes.

 

In accordance with
Section 2.13 of the Indenture, the Company, as designated manager of the Issuer, has duly authorized the issuance and sale of additional
Notes, consisting of $44,000,000 Class A-1 Notes, $5,000,000 Class B-1 Notes, $5,750,000 Class C-1 Notes and $5,250,000 Class D-1
Notes (collectively, the “Additional Offered Notes” and, together with the Initial Offered Notes, the “Offered
Notes”) and $20,000,000 Subordinated Notes (the “Additional Subordinated Notes” and, together with
the Additional Offered Notes, the “Additional Notes” and, together with the Initial Notes, the “Notes”).
On the date of the issuance and sale of the Additional Notes (the “Upsize Date”), the Aggregate Outstanding
Amount of the Notes will be as follows: $132,000,000 Class A-1 Notes, $15,000,000 Class B-1 Notes, $17,250,000 Class C-1 Notes,
$15,750,000 Class D-1 Notes and $60,000,000 Subordinated Notes. The Offered Notes will be secured by the assets of the Issuer.
The Company is the sole equity member of the Issuer. The primary assets of the Issuer are a pool of bank loans, or participation
interests therein (collectively, the “Collateral Obligations”). On the Closing Date, the Company sold to the
Issuer all of its right, title

 

 

    	 

    	 

    
 

and interest in and to the initial Collateral Obligations owned by the Issuer pursuant to a Master
Loan Sale Agreement, dated as of August 23, 2012 (the “Master Loan Sale Agreement”), between the Company and
the Issuer. Pursuant to the Indenture, as security for the indebtedness represented by the Offered Notes, the Issuer pledged and
granted to the Trustee a security interest in the Collateral Obligations, and its rights under the Master Loan Sale Agreement.
The Collateral Obligations are managed by TICC Capital Corp., in its capacity as collateral manager (the “Collateral Manager”)
pursuant to a Collateral Management Agreement, dated as of August 23, 2012 (the “Collateral Management Agreement”),
between the Issuer and the Collateral Manager. The Issuer has retained The Bank of New York Mellon Trust Company, National Association
(in such capacity, the “Collateral Administrator”), to perform certain administrative duties with respect to
the Collateral Obligations pursuant to a Collateral Administration Agreement, dated as of August 23, 2012 (the “Collateral
Administration Agreement”), between the Issuer, the Collateral Manager and the Collateral Administrator. This Upsize
Purchase Agreement (the “Agreement”), the Initial Purchase Agreement, the Master Loan Sale Agreement, the Indenture,
the Collateral Management Agreement and the Collateral Administration Agreement are referred to collectively herein as the “Transaction
Documents.”

 

Capitalized terms used
herein but not otherwise defined shall have the meanings set forth in the Indenture.

 

The Additional Offered
Notes are to be offered without being registered under the Securities Act of 1933, as amended (the “Securities Act”),
(i) to “qualified institutional buyers” in compliance with the exemption from registration provided by Rule 144A under
the Securities Act (“QIBs”), (ii) in offshore transactions in reliance on Regulation S under the Securities
Act (“Regulation S”), and (iii) to institutional “accredited investors” (as defined in Rule 501(a)(1),
(2), (3) or (7) under the Securities Act) (“Institutional Accredited Investors”) who, in each case, are “qualified
purchasers” (“Qualified Purchasers”) for purposes of Section 3(c)(7) under the Investment Company Act
of 1940, as amended (the “1940 Act”).

 

In connection with
the sale of the Additional Offered Notes, the Company has prepared a supplemental offering circular dated January 2, 2013 (including
(A) any exhibits thereto, (B) all information incorporated therein by reference and (C) each monthly report rendered by the Issuer
for the months of October, November and December of 2012 pursuant to the Indenture (the “2012 Monthly Reports”),
the “Supplemental Offering Circular”), the monthly report rendered by the Issuer for the month of January 2013
pursuant to the Indenture (the “January 2013 Monthly Report”) and the distribution report to be rendered by
the Issuer in connection with the Payment Date occurring on February 25, 2013 (which is also the Upsize Date) pursuant to the Indenture
(the “Distribution Report”, and each of the Supplemental Offering Circular, the January 2013 Monthly Report
and the Distribution Report, an “Offering Circular”) including a description of the terms of the Additional
Offered Notes, the terms of the offering, and the Issuer. It is understood and agreed that the close of business on January 24,
2013 constitutes the time of the contract of sale for each purchaser of the Additional Offered Notes offered to the investors for
purposes of Rule 159 under the Securities Act (the “Time of Sale”) and that (i) the Supplemental Offering Circular
and (ii) the January 2013 Monthly Report constitute the entirety of the information conveyed to investors as of the Time of Sale
(the “Time of Sale Information”).

 

    	2

    	 

    
 

It is understood and
agreed that nothing in this Agreement shall prevent the Initial Purchaser from entering into any agency agreements, underwriting
agreements or other similar agreements governing the offer and sale of securities with any issuer or issuers of securities, and
nothing contained herein shall be construed in any way as precluding or restricting the Initial Purchaser’s right to sell
or offer for sale any securities issued by any person, including securities similar to, or competing with, the Additional Notes.

 

During each Interest
Accrual Period, the Class A-1 Notes shall bear interest at a per annum rate equal to the then applicable LIBOR plus 1.75%
per annum, the Class B-1 Notes shall bear interest at a per annum rate equal to the then applicable LIBOR plus 3.50%
per annum, the Class C-1 Notes shall bear interest at a per annum rate equal to the then applicable LIBOR plus 4.75%
per annum, and the Class D-1 Notes shall bear interest at a per annum rate equal to the then applicable LIBOR plus
5.75% per annum.

 

Each of the Company
and the Issuer, as applicable, hereby agrees with the Initial Purchaser as follows:

 

Section 2.               
Purchase and Sale of Additional Offered Notes.

 

Subject to the terms
and conditions and in reliance upon the representations and warranties set forth herein, the Issuer agrees to sell to the Initial
Purchaser the Additional Offered Notes, and the Initial Purchaser has agreed to use its commercially reasonable efforts to place
the aggregate principal amount of Additional Offered Notes set forth on Schedule I hereto with investors in accordance with
the terms hereof. If purchased, the Additional Offered Notes will be purchased at a price of 100%. It is understood and agreed
that the structuring and placement fee payable by the Company on behalf of the Issuer to the Initial Purchaser on the Upsize Date
with respect to the Additional Notes is $829,343.75. Such fees payable by the Company on behalf of the Issuer may be netted by
the Initial Purchaser against its purchase price payment for the Additional Offered Notes. It is understood and agreed that the
Initial Purchaser is not acquiring, and has no obligation to acquire, the Additional Subordinated Notes (which Additional Subordinated
Notes will be acquired by the Company on the Closing Date pursuant to a purchase agreement between the Issuer and the Company (the
“Additional Subordinated Notes Purchase Agreement”)). It is further understood and agreed that the Initial Purchaser
may retain all or any portion of the Additional Offered Notes, purchase the Additional Offered Notes for its own account, or sell
the Additional Offered Notes to its affiliates or to any other investor in accordance with the applicable provisions hereof and
of the Indenture.

 

(a)         In addition, whether or not the transaction contemplated hereby shall be consummated, the Company agrees to pay (or cause
to be paid by the Issuer) all costs and expenses incident to the performance by the Company of its obligations hereunder and under
the documents to be executed and delivered in connection with the offering, issuance, sale and delivery of the Additional Offered
Notes (the “Documents”), including, without limitation or duplication. (i) the fees and disbursements of counsel
to the Company; (ii) the fees and expenses of the Trustee and the Collateral Administrator incurred in connection with the issuance
of the Additional Offered Notes and their or its counsel, as applicable; (iii) [reserved]; (iv) [reserved]; (v) all expenses incurred
in connection with the preparation and distribution of each Offering Circular and other disclosure materials prepared and distributed
and all expenses incurred in

 

    	3

    	 

    
 

connection with the preparation and distribution of the Transaction Documents; (vi) [reserved]; (vii)
[reserved]; (viii) the reasonable fees and disbursements of counsel to the Initial Purchaser; (ix) all expenses in connection with
the qualification of the Additional Offered Notes for offering and sale under state securities laws, including the reasonable fees
and disbursements of counsel and, if requested by the Initial Purchaser, the cost of the preparation and reproduction of any “blue
sky” or legal investment memoranda; (x) any federal, state or local taxes, registration or filing fees (including Uniform
Commercial Code financing statements) or other similar payments to any federal, state or local governmental authority in connection
with the offering, sale, issuance and delivery of the Additional Offered Notes; and (xi) the reasonable fees and expenses of any
special counsel or other experts required to be retained by the Company or the Issuer to provide advice, opinions or assistance
in connection with the offering, issuance, sale and delivery of the Additional Offered Notes.

 

Section 3.               
Delivery.

 

Delivery of the Additional
Offered Notes shall be made in the form of one or more global certificates delivered to The Depository Trust Company, except that
any Additional Offered Note to be sold by the Initial Purchaser to an Institutional Accredited Investor that is also a Qualified
Purchaser for purposes of Section 3(c)(7) of the 1940 Act, but that is not a QIB (as such terms are defined herein), shall be delivered
in fully registered, certificated form in an amount not less than the applicable minimum denomination set forth in the Supplemental
Offering Circular at the offices of Dechert LLP at 10:00 a.m. New York City, New York time, on the Upsize Date. Subject to the
foregoing, the Additional Offered Notes will be registered in such names and such denominations as the Initial Purchaser shall
specify in writing to the Company and the Trustee. The Additional Subordinated Notes shall be delivered to the Company on the Closing
Date in fully registered, certificated form in the permitted denominations and the required proportions set forth in the Supplemental
Offering Circular.

 

Section 4.               
Representations and Warranties of the Company.

 

The Company represents
and warrants to the Initial Purchaser, as of the date hereof and as of the Upsize Date, (a) with respect to the Company, in its
individual capacity, and (b) with respect to the Issuer, in its capacity as designated manager on behalf of the Issuer, that:

 

(i)                
Each Offering Circular, the “Referenced Information” (as defined in the Supplemental Offering Circular) and
any additional information and documents concerning the Additional Offered Notes, including but not limited to one or more marketing
books or preliminary offering circulars, delivered by or on behalf of the Company to prospective purchasers of the Additional Offered
Notes (collectively, such additional information and documents, the “Additional Offering Documents”), did not,
each as of their respective dates or date on which such statement was made and, with respect to the Supplemental Offering Circular
(except for the 2012 Monthly Reports), as of the Upsize Date, include an untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements in each, in light of the circumstances under which they were made, not
misleading; provided that the Company makes no representation or warranty as to the information contained in or omitted
from any Offering Circular or the Additional Offering Documents in reliance upon and in conformity with information furnished in
writing to the Company by or on behalf of the Initial Purchaser referenced in the last sentence of Section 8(a) herein.

 

    	4

    	 

    
 

(ii)              
The Time of Sale Information, as of the Time of Sale, did not contain any untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading; provided that the Company makes no representation or warranty as to the information contained in or omitted
from the Time of Sale Information in reliance upon and in conformity with information furnished in writing to the Company by or
on behalf of the Initial Purchaser referenced in the last sentence of Section 8(a) herein.

 

(iii)            
The Company is a Maryland corporation, duly organized and validly existing under the laws of the State of Maryland, has
all corporate power and authority necessary to own or hold its properties and conduct its business in which it is engaged as described
in the Supplemental Offering Circular and has all licenses necessary to carry on its business as it is now being conducted and
is licensed and qualified in each jurisdiction in which the conduct of its business (including, without limitation, the origination
and acquisition of Collateral Obligations and performing its obligations hereunder and under the other Transaction Documents) requires
such licensing or qualification except where the failure to be so licensed or qualified would not, individually or in the aggregate,
have a material adverse effect on the business, properties, assets, or condition (financial or otherwise) of the Company (a “Material
Adverse Effect”).

 

(iv)            
This Agreement has been duly authorized, executed and delivered by the Company and the Issuer and, assuming due authorization,
execution and delivery thereof by the other parties hereto, constitutes a valid and legally binding obligation of the Company and
the Issuer enforceable against the Company and the Issuer in accordance with its terms, subject, as to enforcement only, to the
effect of bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights
generally or the application of equitable principles in any proceeding, whether at law or in equity.

 

(v)              
Each of the other Transaction Documents has been duly authorized, executed and delivered by the Company and the Issuer,
as applicable, and, assuming due authorization, execution and delivery thereof by the other parties thereto, constitutes the valid
and binding agreement of the Company and the Issuer, as applicable, enforceable against the Company and the Issuer, as applicable,
in accordance with their respective terms, subject, as to enforcement only, to the effect of bankruptcy, insolvency, reorganization,
moratorium and other similar laws relating to or affecting creditors’ rights generally or the application of equitable principles
in any proceeding, whether at law or in equity.

 

    	5

    	 

    
 

(vi)            
The Additional Offered Notes have been duly authorized, and when executed and authenticated in accordance with the Indenture
and delivered to and paid for by the Initial Purchaser in accordance with this Agreement, the Additional Offered Notes will constitute
valid and binding obligations of the Issuer, enforceable against the Issuer in accordance with their terms, subject, as to enforcement
only, to the effect of bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors’
rights generally or the application of equitable principles in any proceeding, whether at law or in equity, and will be entitled
to the benefits of the Indenture.

  

(vii)          
Other than as set forth in or contemplated by each Offering Circular, there are no legal or governmental proceedings pending
to which the Company or the Issuer is a party or of which any property or assets of the Company or the Issuer are the subject of
which could reasonably be expected to materially adversely affect the financial position, stockholders’ equity or results
of operations of the Company or the Issuer or on the performance by the Company or the Issuer of its obligations hereunder or under
the other Transaction Documents; and to the knowledge of the Company, no such proceedings have been threatened or contemplated
by governmental authorities or threatened by others.

 

(viii)        
The execution, delivery and performance of this Agreement and the other Transaction Documents to which it is a party and
the consummation by the Company and the Issuer of the transactions contemplated herein and therein and in all documents relating
to the Notes will not result in any breach or violation of, or constitute a default under, or require any consent under any agreement
or instrument to which the Company or the Issuer is a party or to which any of its properties or assets are subject, except for
such of the foregoing as to which relevant waivers, consents or amendments have been obtained and are in full force and effect,
nor will any such action result in a violation of the organizational documents of the Company or the Issuer or any applicable law,
except, in the case of the Company, for such breaches, violations or defaults that would not, individually or in the aggregate,
have a Material Adverse Effect.

 

(ix)            
Neither the Issuer nor the pool of Collateral Obligations is, or after giving effect to the transactions contemplated by
the Transaction Documents will be, required to be registered as an “investment company” under the 1940 Act.

 

(x)              
Assuming the Initial Purchaser’s representations herein are true and accurate, it is not necessary in connection with
the offer, sale and delivery of the Additional Offered Notes in the manner contemplated by this Agreement and the Supplemental
Offering Circular to register the Additional Offered Notes under the Securities Act or to qualify the Indenture under the Trust
Indenture Act of 1939, as amended.

 

(xi)            
The Additional Offered Notes satisfy the requirements set forth in Rule 144A(d)(3) under the Securities Act. As of the Upsize
Date, the Additional Offered Notes will not be (i) of the same class as securities listed on a national securities exchange in
the United States that is registered under Section 6 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or (ii) quoted in any “automated inter-dealer quotation system” (as such term is used in the Exchange
Act) in the United States.

 

    	6

    	 

    
 

(xii)          
[Reserved].

 

(xiii)        
Upon the execution and delivery of the Transaction Documents, payment by the Initial Purchaser for the Additional Offered
Notes, delivery to the Initial Purchaser of the Additional Offered Notes and delivery to the Company of the Additional Subordinated
Notes, the Initial Purchaser will acquire title to the Additional Offered Notes, in each case free of Liens except such Liens as
may be created or granted by the Initial Purchaser and those permitted in the Transaction Documents.

 

(xiv)        
No consent, authorization or order of, or filing or registration with, any court or governmental agency is required for
the issuance and sale of the Additional Offered Notes or the execution, delivery and performance by the Company or the Issuer,
as applicable, of this Agreement or the other Transaction Documents to which it is a party, except such consents, approvals, authorizations,
filings, registrations or qualifications as have been obtained or as may be required under the Securities Act or state securities
or blue sky laws or the rules and regulations of the Financial Industry Regulatory Authority in connection with the sale and delivery
of the Additional Offered Notes in the manner contemplated herein.

 

(xv)          
The Collateral Obligations in all material respects have the characteristics described in the each Offering Circular.

 

(xvi)        
Each of the representations and warranties of the Company and the Issuer set forth in each of the other Transaction Documents
is true and correct in all material respects.

 

(xvii)      
[Reserved].

 

(xviii)    
Neither the Issuer nor any affiliate (as defined in Rule 501(b) of Regulation D under the Securities Act (“Regulation
D”)) of the Issuer nor anyone acting on their behalf has, directly or indirectly (except to or through the Initial Purchaser),
sold or offered, or attempted to offer or sell, or solicited any offers to buy, or otherwise approached or negotiated in respect
of, any of the Additional Offered Notes and neither the Issuer nor any of its affiliates will do any of the foregoing. As used
herein, the terms “offer” and “sale” have the meanings specified in Section 2(3) of the Securities Act.

 

(xix)        
Neither the Issuer nor any affiliate (as defined in Rule 501(b) of Regulation D) of the Issuer has directly, or through
any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the
Securities Act) which is or will be integrated with the sale of the Additional Offered Notes in a manner that would require the
registration under the Securities Act of the offering contemplated by the Supplemental Offering Circular or engaged in any form
of general solicitation or general advertising in connection with the offering of the Additional Offered Notes.

 

    	7

    	 

    
 

(xx)          
With respect to any Additional Offered Notes subject to the provisions of Regulation S of the Securities Act, the Issuer
has not offered or sold such Additional Offered Notes during the Distribution Compliance Period to a U.S. person or for the account
or benefit of a U.S. person (other than the Initial Purchaser). For this purpose, the term “Distribution Compliance Period”
and “U.S. person” are defined as such term is defined in Regulation S.

 

(xxi)        
Since the date of the latest un-audited financial statements of the Company as of September 30, 2012, there has been no
change nor any development or event involving a prospective change which has had or could reasonably be expected to have a material
adverse change in or effect on (i) the business, operations, properties, assets, liabilities, stockholders’ equity, earnings,
condition (financial or otherwise), results of operations or management of the Company and its subsidiaries, considered as one
enterprise, whether or not in the ordinary course of business, or (ii) the ability of the Company to perform its obligations hereunder
or under the other Transaction Documents.

 

(xxii)      
The Notes and the Transaction Documents conform in all material respects to the descriptions thereof in the Supplemental
Offering Circular.

 

(xxiii)    
Any taxes, fees, and other governmental charges in connection with the execution and delivery of this Agreement and the
other Transaction Documents and the execution, delivery, and sale of the Notes have been or will be paid at or before the Upsize
Date.

 

(xxiv)    
No proceeds received by the Company or the Issuer in respect of the Notes will be used by the Company or the Issuer to acquire
any security in any transaction which is subject to Section 13 or 14 of the Exchange Act.

 

(xxv)      
(i) To the extent applicable thereto, each of the Company, the Issuer and their respective ERISA Affiliates is in compliance
in all material respects with ERISA unless any failure to so comply could not reasonably be expected to have a material adverse
effect and (ii) no lien under Section 303(k) of ERISA or Section 430(k) of the Code exists on any of the Assets. As used in this
paragraph, the term “ERISA Affiliate” means, with respect to any Person, a corporation, trade or business that
is, along with such Person, a member of a controlled group (as described in Section 414 of the Code or Section 4001 of ERISA).

 

(xxvi)    
 The Company has not paid or agreed to pay to any Person any compensation for soliciting another Person to purchase any
of the Additional Offered Notes (except as contemplated by this Agreement).

 

(xxvii)  
The Company has not taken, directly nor indirectly, any action designed to cause or to result in, or that has constituted
or which might reasonably be expected to constitute, the stabilization or manipulation of the price of any Additional Offered Note
or to facilitate the sale or resale of the Additional Offered Notes.

 

    	8

    	 

    
 

(xxviii)
 On and immediately after the Upsize Date, each of the Company and the Issuer (after giving effect to the issuance of the
Additional Notes and to the other transactions related thereto as described in the Time of Sale Information) will be Solvent. As
used in this paragraph, the term “Solvent” means, with respect to a particular date such Person, that on such
date (A) the present fair market value (or present fair saleable value) of the assets of such Person is not less than the total
amount required to pay the probable liabilities of such Person on its total existing debts and liabilities (including contingent
liabilities) as they become absolute and matured, (B) such Person is able to realize upon its assets and pay its debts and other
liabilities, contingent obligations and commitments as they mature and become due in the normal course of business, (C) assuming
the sale of the Additional Offered Notes as contemplated by this Agreement and the Time of Sale Information, such Person is not
incurring debts or liabilities beyond its ability to pay as such debts and liabilities mature and (D) such Person is not engaged
in any business or transaction, and is not about to engage in any business or transaction, for which its property would constitute
unreasonably small capital after giving due consideration to the prevailing practice in the industry in which such Person is engaged.
In computing the amount of such contingent liabilities at any time, it is intended that such liabilities will be computed at the
amount that, in the light of all the facts and circumstances existing at such time, represents the amount that can reasonably be
expected to become an actual or matured liability.

 

Section 5.               
Sale of Additional Offered Notes to the Initial Purchaser.

 

The sale of the Additional
Offered Notes to the Initial Purchaser will be made without registration of the Additional Offered Notes under the Securities Act,
in reliance upon the exemption therefrom provided by Section 4(2) of the Securities Act.

 

(a)               
The Company, the Initial Purchaser and the Issuer hereby agree that the Additional Offered Notes will be offered and sold
only in transactions exempt from registration under the Securities Act. The Company, the Initial Purchaser and the Issuer will
each reasonably believe at the time of any sale of the Additional Offered Notes by the Issuer through the Initial Purchaser (i)
that either (A) each purchaser of the Additional Offered Notes is (1) a QIB who is a Qualified Purchaser purchasing for its own
account (or for the accounts of QIBs who are Qualified Purchasers to whom notice has been given that the resale, pledge or other
transfer is being made in reliance on Rule 144A) in transactions meeting the requirements of Rule 144A, or (2) an Institutional
Accredited Investor who is a Qualified Purchaser who purchases for its own account and provides the Initial Purchaser with a written
certification in substantially the form attached to the Indenture, or (B) each purchaser is acquiring the Additional Offered Notes
in an offshore transaction meeting the requirements of Regulation S and is a Qualified Purchaser, and (ii) that the offering of
the Additional Offered Notes will be made in a manner that will enable the offer and sale of the Additional Offered Notes to be
exempt from registration under state securities or Blue Sky laws; and each such party understands that no action has been taken
to permit a public offering in any jurisdiction where action would be required for such purpose. The Company, the Initial Purchaser
and the Issuer each further agree not to (i) engage (and represents that it has not engaged) in any activity that would constitute
a public offering of the Additional Offered Notes within the meaning of Section 4(2) of the Securities Act or (ii) offer or sell
the Additional Offered Notes by (and represents that it has not engaged in) any form of general solicitation or general advertising
(as those terms are used in Regulation D), including the methods described in Rule 502(c) of Regulation D, in connection with any
offer or sale of the Additional Offered Notes.

 

    	9

    	 

    
 

(b)              
The Initial Purchaser hereby represents and warrants to and agrees with the Company, that (i) it is a QIB and a Qualified
Purchaser and (ii) it will offer the Additional Offered Notes only (A) to persons who it reasonably believes are QIBs who are Qualified
Purchasers in transactions meeting the requirements of Rule 144A, (B) to institutional investors who it reasonably believes are
Institutional Accredited Investors who are Qualified Purchasers or (C) to persons it reasonably believes are Qualified Purchasers
in offshore transactions in accordance with Regulation S. The Initial Purchaser further agrees that (i) it will deliver to each
purchaser of the Additional Offered Notes, at or prior to the Time of Sale, a copy of the Time of Sale Information, as then amended
or supplemented, and (ii) prior to any sale of the Additional Offered Notes to an Institutional Accredited Investor that it does
not reasonably believe is a QIB who is a Qualified Purchaser, it will receive from such Institutional Accredited Investor a written
certification in substantially the applicable form attached to the Indenture.

 

(c)               
The Initial Purchaser hereby represents that it is duly authorized and possesses the requisite limited liability company
power to enter into this Agreement.

 

(d)              
The Initial Purchaser hereby represents there is no action, suit or proceeding pending against or, to the knowledge of the
Initial Purchaser, threatened against or affecting, the Initial Purchaser before any court or arbitrator or any government body,
agency, or official which could reasonably be expected to materially adversely affect the ability of the Initial Purchaser to perform
its obligations under this Agreement.

 

(e)               
The Initial Purchaser hereby represents and agrees that all offers and sales of the Additional Offered Notes by it to non-United
States persons, prior to the expiration of the Distribution Compliance Period, will be made only in accordance with the provisions
of Rule 903 or Rule 904 of Regulation S and only upon receipt of certification of beneficial ownership of the securities by a non-U.S.
person in the form provided in the Indenture. For this purpose, the term “Distribution Compliance Period” and “U.S.
person” are defined as such terms are defined in Regulation S.

 

(f)               
The Initial Purchaser hereby represents that it (i) has not offered or sold, and it will not offer or sell, any Additional
Offered Notes to any Person in the United Kingdom except to (A) investment professionals as defined in Article 19 of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) and investment personnel of the
foregoing, (B) persons who fall within any of the categories of persons described in Articles 49(2)(A) to 49(2)(E) of the Order
(high net worth companies, unincorporated associations, etc.) and investment personnel of the foregoing and (C) any person to whom
it may otherwise lawfully be made, or otherwise in circumstances that have not resulted and will not result in an offer to the
public in the United Kingdom within the meaning of Section 102B of the Financial Services and Markets Act 2000 (the “FSMA”);
(ii) has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to
any Additional Offered Notes in, from or otherwise involving the United Kingdom; and (iii) has only communicated or caused to be
communicated and will only communicate or cause to be communicated any invitation or inducement to engage in investment activity
(within the meaning of Section 21 of the FSMA) received by it in connection with the issue or sale of any Additional Offered Notes
in circumstances in which Section 21(1) of the FSMA does not apply to the Issuer, or to persons to whom such communication may
otherwise lawfully be made.

 

    	10

    	 

    
 

(g)              
In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (as defined
below) (each, a “Relevant Member State”), the Initial Purchaser hereby represents and agrees that effective
from and including the date on which the Prospectus Directive is implemented in that Relevant Member State (the “Relevant
Implementation Date”) it has not made and will not make an offer of the Additional Offered Notes to the public in that
Relevant Member State prior to the publication of a prospectus in relation to the Additional Offered Notes which has been approved
by the competent authority in that Relevant Member State or, where appropriate, approved in another Relevant Member State and notified
to the competent authority in that Relevant Member State, all in accordance with the Prospectus Directive, except that it may,
effective from and including the Relevant Implementation Date, make an offer of the Additional Offered Notes to the public in that
Relevant Member State at any time:

 

(i)                
to legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated,
whose corporate purpose is solely to invest in securities:

 

(ii)              
to any legal entity which has two or more of (1) an average of at least 250 employees during the last financial year; (2)
a total balance sheet of more than €43,000,000 and (3) an annual net turnover of more than €50,000,000, as shown in its
last annual or consolidated financial statements; or

 

(iii)            
in any other circumstances which do not require the publication by the issuer of a prospectus pursuant to Article 3 of the
Prospectus Directive.

 

For the purposes of
this Section 5(g), the expression “offer of Additional Offered Notes to the public” in relation to any Additional
Offered Notes in any Relevant Member State means the communication in any form and by any means of sufficient information on the
terms of the offer and the Additional Offered Notes so as to enable an investor to decide to purchase or subscribe the Additional
Offered Notes, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member
State and the expression “Prospectus Directive” means Directive 2003/71/EC and includes any relevant implementing
measure in each Relevant Member State.

 

Section 6.               
Certain Agreements of the Company.

 

The Company covenants
and agrees with the Initial Purchaser as follows:

 

    	11

    	 

    
 

(a)               
If, at any time prior to the 90th day following the Upsize Date, any event involving the Company, the Issuer or, to the
knowledge of a Responsible Officer of the Company, the Collateral Manager shall occur as a result of which the Supplemental Offering
Circular (as then amended or supplemented) would include an untrue statement of a material fact or omit to state any material fact
necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Company
will immediately notify the Initial Purchaser and will cause the Issuer to prepare and furnish to the Initial Purchaser an amendment
or supplement to the Supplemental Offering Circular that will correct such statement or omission. The Issuer will not at any time
amend or supplement the Supplemental Offering Circular (i) prior to having furnished the Initial Purchaser with a copy of the proposed
form of the amendment or supplement and giving the Initial Purchaser a reasonable opportunity to review the same or (ii) except
to the extent the Company may determine it or the Issuer is required to so disclose pursuant to applicable law and after consultation
with the Initial Purchaser (and, in such a circumstance, shall remove all references to the Initial Purchaser therefrom if so requested
by the Initial Purchaser), in a manner to which the Initial Purchaser or its counsel shall object.

 

(b)              
During the period referred to in Section 6(a), the Company will furnish to the Initial Purchaser, without charge,
copies of the Supplemental Offering Circular (including all exhibits and documents incorporated by reference therein), the Transaction
Documents, and all amendments or supplements to such documents, in each case, as soon as reasonably available and in such quantities
as the Initial Purchaser may from time to time reasonably request.

 

(c)               
Subject to compliance with Regulation FD, at all times during the course of the private placement contemplated hereby and
prior to the Upsize Date, (i) the Company will make available to each offeree the Additional Offering Documents and such information
concerning any other relevant matters as it or any of its affiliates possess or can acquire without unreasonable effort or expense,
as determined in good faith by it or such affiliate, as applicable, (ii) the Company will provide each offeree the opportunity
to ask questions of, and receive answers from, it concerning the terms and conditions of the offering and to obtain any additional
information, to the extent it or any of its affiliates possess such information or can acquire it without unreasonable effort or
expense (as determined in good faith by it or such affiliate, as applicable), necessary to verify the accuracy of the information
furnished to the offeree, (iii) the Company will not publish or disseminate any material in connection with the offering of the
Additional Offered Notes except as contemplated herein or as consented to by the Initial Purchaser or in connection with the Company’s
disclosure obligations under the Exchange Act, provided that no such disclosure under the Exchange Act would result in a
requirement that the offering of the Notes be registered under §5 of the Securities Act, (iv) the Company will advise the
Initial Purchaser promptly of the receipt by the Company of any communication from the SEC or any state securities authority concerning
the offering or sale of the Additional Offered Notes, (v) the Company will advise the Initial Purchaser promptly of the commencement
of any lawsuit or proceeding to which the Company is a party relating to the offering or sale of the Additional Offered Notes,
and (vi) the Company will advise the Initial Purchaser of the suspension of the qualification of the Additional Offered Notes for
offering or sale in any jurisdiction, or the initiation or threat of any procedure for any such purpose.

 

    	12

    	 

    
 

(d)              
Subject to compliance with Regulation FD, the Company will furnish, upon the written request of any Noteholder or of any
owner of a beneficial interest in a Note, such information as is specified in paragraph (d)(4) of Rule 144A under the Securities
Act (i) to such Noteholder or beneficial owner, (ii) to a prospective purchaser of such Note or interest therein who is a QIB and
a Qualified Purchaser designated by such Noteholder or beneficial owner, or (iii) to the Trustee for delivery to such Noteholder,
beneficial owner or prospective purchaser, in order to permit compliance by such Noteholder or beneficial owner with Rule 144A
in connection with the resale of such Note or beneficial interest therein by such holder or beneficial owner in reliance on Rule
144A unless, at the time of such request, the Issuer is subject to the reporting requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934 or is exempt from such reporting requirements pursuant to and in compliance with Rule 12g3-2(b).

 

(e)               
Except as otherwise provided in the Indenture, each Additional Offered Note will contain legends in the forms set forth
in the Supplemental Offering Circular.

 

(f)               
Neither the Issuer nor any of its affiliates or any other Person acting on their behalf shall engage, in connection with
the offer and sale of the Additional Offered Notes, in any form of general solicitation or general advertising within the meaning
of Rule 502(c) of Regulation D under the Securities Act, including, but not limited to, the following:

 

(i)                
any advertisement, article, notice or other communication published in any newspaper, magazine or similar medium or broadcast
over television or radio; and

 

(ii)              
any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

 

(g)              
The Issuer shall not solicit any offer to buy from or offer to sell or sell to any Person any Additional Offered Notes,
except through the Initial Purchaser or with the consent of the Initial Purchaser and/or as otherwise specified in the Indenture
at any time prior to the Upsize Date; on or prior to the Upsize Date, neither the Issuer nor any of its affiliates (except for
compliance by the Company with Regulation FD) shall publish or disseminate any material other than the Additional Offering Documents
consented to by the Initial Purchaser and the Time of Sale Information in connection with the offer or sale of the Additional Offered
Notes as contemplated by this Agreement, unless the Initial Purchaser shall have consented to the use thereof; if the Issuer or
any of its affiliates makes any press release including “tombstone” announcements, in connection with the Transaction
Documents, the Issuer shall permit the Initial Purchaser to review and approve such release in advance.

 

(h)              
The Issuer shall not take, or permit or cause any of its affiliates to take, any action whatsoever which would have the
effect of requiring the registration, under the Securities Act, of the offer or sale of the Additional Offered Notes.

 

(i)                
The Issuer shall not take, directly or indirectly, any action designed to or which has constituted or which might reasonably
be expected to cause or result, under the Exchange Act or otherwise, in stabilization or manipulation of the price of any Additional
Offered Note to facilitate the sale or resale of the Additional Offered Notes.

 

(j)                
The Company shall apply the net proceeds from the sale of the Additional Offered Notes as set forth in the Section 2.13
of the Indenture.

 

    	13

    	 

    
 

Section 7.               
Conditions of the Initial Purchaser Obligations.

 

The obligation of the
Initial Purchaser to purchase the Additional Offered Notes on the Upsize Date will be subject to the accuracy, in all material
respects, of the representations and warranties of the Company and the Issuer herein, to the performance, in all material respects,
by the Company and the Issuer of their respective obligations hereunder and to the following additional conditions precedent:

 

(a)               
The Additional Offered Notes shall have been duly authorized, executed, authenticated, delivered and issued, the Transaction
Documents shall have been duly authorized, executed and delivered by the respective parties thereto and shall be in full force
and effect, and the documents required to be delivered pursuant to the Indenture in respect of the Collateral Obligations shall
have been delivered to the Custodian pursuant to and as required by the Transaction Documents.

 

(b)              
The Initial Purchaser shall have received (I) a certificate, dated as of the Closing Date, of the Chief Executive Officer
or Chief Financial Officer of the Company, in its individual capacity (and, with respect to the Issuer, in its capacity as designated
manager on behalf of the Issuer), to the effect that such officer has carefully examined this Agreement, the Supplemental Offering
Circular and the Transaction Documents and that, to the best of such officer’s knowledge (i) since the date information is
given in the Supplemental Offering Circular, there has not been any material adverse change in the condition, financial or otherwise,
or in the earnings, business affairs or business prospects of the Company or the Issuer whether or not arising in the ordinary
course of business, or the ability of the Company or the Issuer to perform its obligations hereunder or under the Transaction Documents,
(ii) each of the Company and the Issuer has complied in all material respects with all agreements and satisfied all conditions
on its part to be performed or satisfied hereunder and under the other Transaction Documents, at or prior to the Upsize Date, (iii)
the representations and warranties of the Company and the Issuer in the Transaction Documents are true and correct in all material
respects, as of the Upsize Date, as though such representations and warranties had been made on and as of such date, and (iv) nothing
has come to the attention of such officer that would lead such officer to believe that (A) the Time of Sale Information, as of
the Time of Sale, contained any untrue statement of a material fact or omits to state a material fact necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading, and (B) the Supplemental Offering
Circular, as of its date and as of the Upsize Date, or any Additional Offering Document, as of its respective date, contained or
contains an untrue statement of a material fact or omits to state any material fact necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading and (II) a certificate, dated as of the Upsize Date, of
senior officer of the Company to the effect that such officer has carefully examined the Supplemental Offering Circular and that,
to the best of such officer’s knowledge, nothing has come to the attention of such officer that would lead such officer to
believe that the information contained in the Supplemental Offering Circular under the heading “Risk Factors—Relating
to Certain Conflicts of Interest—Certain Conflicts of Interest Relating to the Collateral Manager and its Affiliates”,
as of the date of the Supplemental Offering Circular and as of the Upsize Date, contained any untrue statement of a material fact
or omits to state a material fact necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading.

 

    	14

    	 

    
 

(c)               
The Class A-1 Notes shall have been rated no less than “Aaa (sf)” and “AAA (sf)” by
Moody’s and S&P, respectively, the Class B-1 Notes shall have been rated no less than “Aa2 (sf)” and
“AA (sf)” by Moody’s and S&P, respectively, the Class C-1 Notes shall have been rated no less than
“A2 (sf)” and “A (sf)” by Moody’s and S&P, respectively, and the Class D-1 Notes
shall have been rated no less than “Baa2 (sf)” and “BBB (sf)” by Moody’s and S&P,
respectively. Such ratings shall not have been rescinded, and no public announcement shall have been made by either of Moody’s
or S&P that any ratings of the Offered Notes have been placed under review.

 

(d)              
[Reserved].

 

(e)               
[Reserved].

 

(f)               
The Initial Purchaser shall have received legal opinions of Sutherland Asbill & Brennan LLP, counsel to the Company,
the Issuer and the Collateral Manager, with respect to certain corporate matters with respect to the Issuer, the Company and the
Collateral Manager and certain securities law and investment company matters, in form and substance satisfactory to the Initial
Purchaser, in form and substance satisfactory to the Initial Purchaser.

 

(g)              
The Initial Purchaser shall have received an opinion of Dechert LLP, special U.S. federal income tax counsel to the Issuer,
with respect to the treatment of the Additional Offered Notes as debt for U.S. federal income tax purposes and in form and substance
satisfactory to the Initial Purchaser.

 

(h)              
[Reserved].

 

(i)                
The Initial Purchaser shall have received from the Trustee a certificate signed by one or more duly authorized officers
of the Trustee, dated as of the Upsize Date, in customary form.

 

(j)                
The Company shall have furnished to the Initial Purchaser and its counsel such further information, certificates and documents
as the Initial Purchaser and its counsel may reasonably have requested, and all proceedings in connection with the transactions
contemplated by this Agreement, the other Transaction Documents and all documents incident hereto shall be in all respects satisfactory
in form and substance to the Initial Purchaser and its counsel.

 

(k)              
The Company shall have purchased or otherwise acquired the Additional Subordinated Notes in accordance with the terms of
the Additional Subordinated Notes Purchase Agreement.

 

(l)                
The Indenture, the Master Loan Sale Agreement, the Collateral Management Agreement and all other documents incident hereto
and to the other Transaction Documents shall be reasonably satisfactory in form and substance to the Initial Purchaser and its
counsel.

 

If any of the conditions
specified in this Section 7 shall not have been fulfilled in all material respects when and as provided in this Agreement,
or if any of the opinions and certificates mentioned above shall not be satisfactory in form and substance to the Initial Purchaser,
this Agreement and all of the Initial Purchaser’s obligations hereunder may be canceled by the Initial Purchaser at or prior
to delivery of and payment for the Additional Offered Notes. Notice of such cancellation shall be given to the Company in writing,
or by telephone or facsimile confirmed in writing.

 

    	15

    	 

    
 

Section 8.               
Indemnification and Contribution.

 

(a)               
The Company and the Issuer, jointly and severally (each an “indemnifying party” as such term is used
in this Agreement), shall indemnify and hold harmless the Initial Purchaser (whether acting as Initial Purchaser or as placement
agent with respect to any of the Additional Offered Notes), its officers, directors, employees, agents and each person, if any,
who controls the Initial Purchaser within the meaning of either the Securities Act or the Exchange Act and the affiliates of the
Initial Purchaser (each an “indemnified party” as such term is used in this Agreement) from and against any
loss, claim, damage or liability, joint or several, and any action in respect thereof, to which any indemnified party may become
subject, under the Securities Act or Exchange Act or otherwise, insofar as such loss, claim, damage, liability or action arises
out of, or is based upon, any untrue statement or alleged untrue statement of a material fact contained in any Offering Circular,
any Additional Offering Document, any “Referenced Information” (as defined in the Supplemental Offering Circular) or
the Time of Sale Information or arises out of, or is based upon, the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein in light of the circumstances under which they were made
not misleading, and shall reimburse any such indemnified party for any legal and other expenses incurred by such indemnified party
in investigating or defending or preparing to defend against any such loss, claim, damage, liability or action; provided,
however, that the indemnifying parties shall not be liable to any such indemnified party in any such case to the extent
that any such loss, claim, damage, liability or action arises out of, or is based upon, any untrue statement or alleged untrue
statement or omission or alleged omission made in the Time of Sale Information, any Offering Circular or any Additional Offering
Document in reliance upon and in conformity with written information furnished to the Company by such indemnified party specifically
for inclusion therein. The foregoing indemnity is in addition to any liability that the indemnifying parties may otherwise have
to any indemnified party. The indemnifying parties acknowledge that the statements set forth in the Time of Sale Information and
any Offering Circular relating to the Initial Purchaser in the third and fourth sentence of the third paragraph on page i of the
Supplemental Offering Circular under the heading “Important Notice Regarding the Additional Offered Notes” constitute
the only written information furnished to the Company by or on behalf of the indemnified parties specifically for inclusion in
the Time of Sale Information, any Offering Circular or any Additional Offering Document.

 

    	16

    	 

    
 

(b)              
Promptly after receipt by an indemnified party under this Section 8 of notice of any claim or the commencement of
any action, the indemnified party shall, if a claim in respect thereof is to be made against an indemnifying party under this Section
8, notify such indemnifying party in writing of the claim or commencement of that action, provided, however,
that the failure to notify an indemnifying party shall not relieve such indemnifying party from any liability that it may have
to an indemnified party under this Section 8, except to the extent that such indemnifying party has been materially prejudiced
by such failure and, provided, further, that the failure to notify an indemnifying party shall not relieve such indemnifying
party from any liability that it may have to an indemnified party otherwise than under this Section 8. If any such claim
or action shall be brought against an indemnified party, and it shall notify an indemnifying party thereof, such indemnifying party
shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying
party, to assume the defense thereof with counsel reasonably satisfactory to such indemnified party. After notice from any such
indemnifying party or parties to the indemnified party or parties of its or their election to assume the defense of such claim
or action, any such indemnifying party or parties shall not be liable to the indemnified party under this Section 8 for
any legal or other expenses subsequently incurred by the indemnified party or parties in connection with the defense thereof; provided
that the indemnified party seeking such indemnity shall have the right to employ counsel to represent it and any other indemnified
party who may be subject to liability arising out of any claim or action in respect of which indemnity may be sought by an indemnified
party against an indemnifying party under this Section 8, if (i) in the reasonable judgment of counsel, there may be legal
defenses available to such indemnified party and any other indemnified party different from or in addition to those available to
the Company or the Issuer, or there is an actual conflict of interest between it and any other indemnified party, on one hand,
and the Company or the Issuer, on the other, or (ii) the Company or the Issuer shall fail to select counsel reasonably satisfactory
to such indemnified party or parties, and in such event the fees and expenses of such separate counsel shall be paid by the Company
and the Issuer. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement
of any pending or threatened proceeding in respect of which any indemnified party is or could have been a party and indemnity could
have been sought hereunder by such indemnified party, unless such settlement (i) does not include a statement as to, or admission
of, fault, culpability or a failure to act by or on behalf of any such indemnified party, and (ii) includes an unconditional release
of such indemnified party from all liability on claims that are the subject matter of such proceeding.

 

(c)               
If the indemnification provided for in Section 8 shall for any reason be unavailable to an indemnified party under
subsection 8(a) hereof in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to
therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid or payable
by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in such proportion
as shall be appropriate to reflect the relative benefits received by the Company and the Issuer on the one hand (without duplication)
and the Initial Purchaser on the other from the offering and sale of the Additional Offered Notes or (ii) if the allocation provided
by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative
benefits referred to in clause (i) above but also the relative fault of the Company and the Issuer on the one hand and the Initial
Purchaser on the other with respect to the statements or omissions that resulted in such loss, claim, damage or liability, or action
in respect thereof, as well as any other relevant equitable considerations. The relative benefits received by the Company and the
Issuer on the one hand (without duplication) and the Initial Purchaser on the other with respect to such offering shall be deemed
to be in the same proportion as the total net proceeds from the offering and sale of the Additional Offered Notes (before deducting
expenses) received by the Company and the Issuer bear (without duplication) to the total fees actually received by the Initial
Purchaser with respect to such offering and sale. The relative fault shall be determined by reference to whether the untrue or
alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied
by the Company and the Issuer or by the Initial Purchaser, the intent of the parties and their relative knowledge, access to information
and

 

    	17

    	 

    
 

opportunity to correct or prevent such statement or omission. The Company, the Issuer and the Initial Purchaser agree that
it would not be just and equitable if contributions pursuant to this subsection 8(c) were to be determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein.
The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof,
referred to above in this subsection 8(c) shall be deemed to include, for purposes of this subsection 8(c), any legal
or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or
claim. Notwithstanding the provisions of this subsection 8(c), the Initial Purchaser shall not be required to contribute
any amount in excess of the aggregate fee actually paid to the Initial Purchaser with respect to the offering of the Additional
Offered Notes. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall
be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

 

(d)              
The indemnity agreements contained in this Section 8 shall survive the delivery of the Additional Offered Notes,
and the provisions of this Section 8 shall remain in full force and effect, regardless of any termination or cancellation
of this Agreement or any investigation made by or on behalf of any indemnified party.

 

(e)               
Notwithstanding any other provision in this Section 8, no party shall be entitled to indemnification or contribution
under this Agreement in violation of Section 17(i) of the 1940 Act.

 

Section 9.               
Termination.

 

This Agreement shall
be subject to termination in the absolute discretion of the Initial Purchaser, by notice given to the Company prior to delivery
of and payment for the Additional Offered Notes, if prior to such time (i) trading in securities generally on the New York Stock
Exchange shall have been suspended or materially limited or any setting of minimum prices for trading on such exchange shall have
occurred, (ii) there shall have been, since the respective dates as of which information is given in the Time of Sale Information
or the Supplemental Offering Circular, any material adverse change in the condition, financial or otherwise, or in the properties
(including, without limitation, the Collateral Obligations) or the earnings, business affairs or business prospects of the Company,
the Issuer or the Collateral Manager, whether or not arising in the ordinary course of business, that is so material and adverse,
in the reasonable judgment of the Initial Purchaser, as to make it impractical or inadvisable to market the Additional Offered
Notes; (iii) a general moratorium on commercial banking activities in New York shall have been declared by either U.S. federal
or New York State authorities, or (iv) there shall have occurred any material outbreak or escalation of hostilities or other calamity
or crises the effect of which on the financial markets of the United States is such as to make it, in the reasonable judgment of
the Initial Purchaser, impracticable or inadvisable to market the Additional Offered Notes.

 

    	18

    	 

    
 

Section 10.           
Severability Clause.

 

Any part, provision,
representation, or warranty of this Agreement which is prohibited or is held to be void or unenforceable in any jurisdiction shall,
as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining
provisions hereof.

 

Section 11.           
Notices.

 

All demands, notices
and communications hereunder shall be in writing and shall be deemed to have been duly given if personally delivered at or mailed
by overnight mail, certified mail or registered mail, postage prepaid and effective only upon receipt and if sent to the Initial
Purchaser, will be delivered to Guggenheim Securities, LLC, 135 East 57th Street, 7th Floor, New York, New York 10022,
Attention: Chief Operating Officer and to Guggenheim Securities, LLC, 135 East 57th Street, 7th Floor, New York, New
York 10022, Attention: General Counsel; or if sent to the Company or the Issuer will be delivered to such party c/o TICC Capital
Corp., 8 Sound Shore Drive, Suite 255, Greenwich, CT 06830, Attention: Saul Rosenthal, facsimile No. (203) 983-5290.

 

Section 12.           
Representations and Indemnities to Survive.

 

The respective agreements,
representations, warranties, indemnities and other statements of the Company, the Issuer and their respective officers and of the
Initial Purchaser set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation
made by or on behalf of the Initial Purchaser, the Company, the Issuer or any indemnified party referred to in Section 8
of this Agreement, and will survive delivery of and payment for the Additional Offered Notes.

 

Section 13.           
Successors.

 

This Agreement will
inure to the benefit of and be binding upon the parties hereto and their respective successors by merger, consolidation or acquisition
of their assets substantially as an entity and each indemnified party referred to in Section 8 of this Agreement and, except
as specifically set forth herein, no other person will have any right or obligation hereunder.

 

Section 14.           
Applicable Law.

 

(a)               
THIS AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS
5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES).

 

(b)              
EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY REQUIREMENTS OF LAW, ANY RIGHT IT MAY HAVE TO A TRIAL
BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT. EACH PARTY
HERETO (I) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT
SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (II) ACKNOWLEDGES THAT IT AND
THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION 14(b).

 

    	19

    	 

    
 

(c)               
ANY LEGAL ACTION OR PROCEEDING WITH RESPECT TO THIS AGREEMENT MAY BE BROUGHT IN THE COURTS OF THE UNITED STATES FOR THE
SOUTHERN DISTRICT OF NEW YORK, AND BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH PARTY HERETO CONSENTS, FOR ITSELF AND IN RESPECT
OF ITS PROPERTY, TO THE NON—EXCLUSIVE JURISDICTION OF THOSE COURTS. EACH SUCH PARTY IRREVOCABLY WAIVES ANY OBJECTION, INCLUDING
ANY OBJECTION TO THE LAYING OF VENUE OR BASED ON THE GROUNDS OF FORUM NON CONVENIENS, WHICH IT MAY NOW OR HEREAFTER HAVE TO THE
BRINGING OF ANY ACTION OR PROCEEDING IN SUCH JURISDICTION IN RESPECT OF THIS AGREEMENT OR ANY DOCUMENT RELATED HERETO.

 

Section 15.           
Counterparts, Etc.

 

This Agreement supersedes
all prior or contemporaneous agreements and understandings relating to the subject matter hereof. Neither this Agreement nor any
term hereof may be changed, waived, discharged or terminated except by a writing signed by the party against whom enforcement of
such change, waiver, discharge or termination is sought. This Agreement may be signed in any number of counterparts each of which
shall be deemed an original, which taken together shall constitute one and the same instrument.

 

Section 16.           
No Petition; Limited Recourse.

 

(a)               
The Initial Purchaser covenants and agrees that, prior to the date that is one year and one day (or such longer preference
period as shall then be in effect plus one day) after the payment in full of each Class of Notes rated by any Rating Agency, it
will not institute against the Issuer or join any other Person in instituting against the Issuer any bankruptcy, reorganization,
arrangement, insolvency or liquidation proceedings or other similar proceedings under the laws of the United States or any state
of the United States.

 

(b)              
Notwithstanding anything to the contrary herein, the obligations of the Issuer hereunder are limited recourse obligations
of the Issuer, payable solely from the Assets securing the Notes, and following the exhaustion of such Assets, any claims of the
Initial Purchaser hereunder against the Issuer shall be extinguished. All payments by the Issuer to the Initial Purchaser hereunder
shall be made subject to and in accordance with the Priority of Payments set forth in the Indenture.

 

(c)               
This Section 16 will survive the termination of this Agreement.

 

    	20

    	 

    
 

Section 17.           
Arm’s-Length Transaction; Other Transactions.

 

(a)               
Each of the Company and the Issuer acknowledges and agrees that (i) the purchase and sale of the Additional Offered Notes
pursuant to this Agreement, including the determination of the offering price of the Additional Offered Notes and any related discounts
and commissions, is an arm’s-length commercial transaction between the Issuer, on the one hand, and the Initial Purchaser,
on the other hand, (ii) in connection with the offering contemplated hereby and the process leading to such transaction, the Initial
Purchaser is and has been acting solely as a principal and is not an agent or fiduciary of the Issuer or the Company or any of
their respective equity holders, creditors, employees or any other party, (iii) the Initial Purchaser has not assumed and will
not assume an advisory or fiduciary responsibility in favor of the Issuer or the Company with respect to the offering contemplated
hereby or the process leading thereto (irrespective of whether the Initial Purchaser has advised or is currently advising any of
the Issuer or the Company on other matters) and the Initial Purchaser has no obligation to any of the Issuer or the Company with
respect to the offering contemplated hereby, except the obligations expressly set forth in this Agreement, and (iv) the Initial
Purchaser has not provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated hereby and
each of the Issuer and the Company has consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed
appropriate.

 

(b)              
Each of the Company and the Issuer acknowledges and agrees that the Initial Purchaser and its Affiliates may presently have
and may in the future have investment and commercial banking, trust and other relationships with parties other than the Company
and the Issuer, which parties may have interests with respect to the purchase and sale of the Additional Offered Notes. Although
the Initial Purchaser in the course of such other relationships may acquire information about the purchase and sale of the Additional
Offered Notes, potential purchasers of the Additional Offered Notes or such other parties, the Initial Purchaser shall not have
any obligation to disclose such information to any of the Company or the Issuer. Furthermore, each of the Company and the Issuer
acknowledges that the Initial Purchaser may have fiduciary or other relationships whereby the Initial Purchaser may exercise voting
power over securities of various persons, which securities may from time to time include securities of any of the Company or the
Issuer or their respective Affiliates or of potential purchasers. Each of the Company and the Issuer acknowledges that the Initial
Purchaser may exercise such powers and otherwise perform any functions in connection with such fiduciary or other relationships
without regard to its relationship to the Company or the Issuer hereunder.

 

[REST OF
PAGE INTENTIONALLY LEFT BLANK]

 

    	21

    	 

    

If the foregoing is
in accordance with your understanding of our agreement, please sign and return to the undersigned a counterpart hereof, whereupon
this letter and your acceptance shall represent a binding agreement among the Company, the Issuer and the Initial Purchaser.

 

Very truly yours,

 

TICC CAPITAL CORP.

 

 

By:__________________________

Name:____________________

Title:_____________________

    	S-1

    	 

    

TICC CLO 2012-1 LLC

 

 

By: TICC Capital Corp., its
designated manager

 

 

By: __________________________

Name:_____________________

Title:______________________

 

    	S-2

    	 

    

The foregoing Agreement is hereby confirmed and

accepted as of the date first above written.

 

GUGGENHEIM SECURITIES, LLC,

as the Initial Purchaser

 

 

By: _______________________________

Name: _____________________________

Title: ______________________________

    	S-3

    	 

    

SCHEDULE I

 

	Class of Notes	Principal Amount
	A-1	$44,000,000
	B-1	$5,000,000
	C-1	$5,750,000
	D-1	$5,250,000

 

 

    	Sch. I-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]